Free tool
Oncology stocks
We cover 6 companies grouped under the Oncology theme. The median market value in the group is $4.26B. Across the group, the median move over the past trading day is +1.75%. Price change over the past year runs from −43.3% to +37.3% across the middle 80 percent of the group, with a median of −5.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
6 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $73.00B | Large cap | +12.47% | Oct 27, 2026 |
| 4568.T | Daiichi Sankyo Company, Limited | $33.36B | Large cap | −15.95% | Oct 30, 2026 |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +62.22% | Oct 29, 2026 |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +4.54% | Nov 13, 2026 |
| 4587.T | PeptiDream Inc. | $902.75M | Small cap | −28.26% | Nov 11, 2026 |
| 4582.T | SymBio Pharmaceuticals Limited | $31.73M | Micro cap | −58.28% | Oct 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.